https://pharmoniq.com/news/fda-approves-rasonque-metastatic-pancreatic-cancer PharmoniQ en 2026-10-07T14:10:49.869Z FDA Approves Rasonque for Metastatic Pancreatic Cancer Treatment FDA approval, pancreatic cancer, oncology, metastatic cancer, Rasonque https://pharmoniq.com/news/fda-approves-pirtobrutinib-first-line-blood-cancer-treatment PharmoniQ en 2026-10-06T14:10:49.397Z FDA Approves Pirtobrutinib as First-Line Blood Cancer Treatment FDA approval, oncology, blood cancer, pirtobrutinib, Eli Lilly https://pharmoniq.com/news/shionogi-acquires-intrabio-2-billion-rare-disease-expansion PharmoniQ en 2026-10-06T08:47:02.190Z Shionogi Acquires IntraBio for $2B in Rare Disease Push mergers-acquisitions, rare-disease, shionogi, biotech, orphan-drugs